ENTA – enanta pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at HC Wainwright from $28.00 to $27.00. They now have a "buy" rating on the stock.
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JMP Securities from $23.00 to $22.00. They now have a "market outperform" rating on the stock.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript [Yahoo! Finance]
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]
Form 8-K ENANTA PHARMACEUTICALS For: May 06
Form 4 ENANTA PHARMACEUTICALS For: Apr 29 Filed by: Kowalsky Matthew Paul
Form 3 ENANTA PHARMACEUTICALS For: Apr 29 Filed by: Kowalsky Matthew Paul
Form 8-K ENANTA PHARMACEUTICALS For: Mar 06
Form 4 ENANTA PHARMACEUTICALS For: Mar 06 Filed by: Vance Terry
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.